| First Author | Ishiguro K | Year | 2000 |
| Journal | Dev Dyn | Volume | 219 |
| Issue | 4 | Pages | 539-44 |
| PubMed ID | 11084653 | Mgi Jnum | J:65874 |
| Mgi Id | MGI:1927405 | Doi | 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1081>3.0.CO;2-K |
| Citation | Ishiguro K, et al. (2000) Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth. Dev Dyn 219(4):539-44 |
| abstractText | Syndecan-4 is a transmembrane protein bearing heparan sulfate chains, involved in anticoagulation and focal adhesion formation. Here, we revealed that syndecan-4 was expressed in the fetal vessels in the placental labyrinth by in situ hybridization and immunohistochemical staining. At 17.5 gestational days, the area of degenerated fetal vessels in the placental labyrinth was more diffuse and larger in Synd4(-/-) embryos than wild-type controls. Calcium and fibrin(ogen) depositions in the degenerated vessels were also more extensive and more severe in the placentas of Synd4(-/-) embryos. These findings suggest that syndecan-4 deficiency impairs the fetal vessels in the placenta, probably due to a deficit in the anticoagulation mechanism. This article is the first report demonstrating that among a large number of core proteins of heparan sulfate proteoglycans, a defect of a single core protein caused impaired anticoagulation in a specific site. Copyright 2000 Wiley-Liss, Inc. |
